Home
Affinia Therapeutics

Affinia Therapeutics Market Share Analysis for June 2026

Check out the latest career opportunities at Affinia Therapeutics and apply today.

Industry: N/A

Domainaffiniatx.com

Year Founded2019

Employees51 - 200

Annual Revenue$2M - $5M

Affinia Therapeutics

Affinia Therapeutics (including company regionals)

affiniatx.com

See more website traffic and engagement information

Affinia Therapeutics Revenue up to June 2026 is 2M - 5M

revenue generated by Affinia Therapeutics top domains

Affinia Therapeutics top domains revenue over 3 years

Revenue for Affinia Therapeutics top domains

affiniatx.com2M - 5M

See more with Sales Intelligence

Total visits to Affinia Therapeutics's top domains

Understand Affinia Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

affiniatx.com2K

See more with Sales Intelligence

Avg. visit duration in Affinia Therapeutics's top domains

Analyze Affinia Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

affiniatx.com00:00:33

See more with Sales Intelligence

Avg. pageviews on Affinia Therapeutics's top domains

See how Affinia Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

affiniatx.com1.80

See more with Sales Intelligence

Affinia Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Affinia Therapeutics

These are the website technologies, by industry, used by Affinia Therapeutics top domains

Widget (6)

Twemoji

Content Management System (3)

WordPress

Email Services (3)

Microsoft Exchange Online

Advertising (2)

DoubleClick

More Technologies

9

See all

News & Signals from Affinia Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAffinia Therapeutics, Inc. attends event American Society of Gene & Cell Therapy 2026 Annual Meeting.Affinia Therapeutics to present AFTX-201 for bag3-associated dilated cardiomyopathy (DCM) and highlight proprietary capsid engineering and manufacturing data at the American Society of Gene & Cell Therapy 2026 Annual Meeting.

NewsNew Enterprise Associates invested into Affinia Therapeutics, Inc. $40M in Series C on Oct 1st '25.In October 2025, Affinia Therapeutics raised $40m in a Series C funding round, led by New Enterprise Associates.